We are live on ! Find out more
SMC

S. Muoio & Co Portfolio holdings

AUM $75.7M
1-Year Est. Return 42.51%
This Fund
S&P 500
This Quarter Est. Return
+16.77%
1 Year Est. Return
+42.51%
3 Year Est. Return
+327.42%
5 Year Est. Return
+691.71%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$15.9M
Cap. Flow
+$9.02M
Cap. Flow %
8.11%
Top 10 Hldgs %
47.05%
Holding
91
New
16
Increased
10
Reduced
12
Closed
20

Top Buys

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$3.56M
2
AGN
Allergan plc
AGN
+$2.16M
3
BOLD
Audentes Therapeutics, Inc
BOLD
+$2.14M
4
WBC
WABCO HOLDINGS INC.
WBC
+$2.02M
5
GBL
GAMCO Investors, Inc.
GBL
+$1.41M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$7.92M
2
CBM
Cambrex Corporation
CBM
+$2.99M
3
VIAB
Viacom Inc. Class B
VIAB
+$2.84M
4
GWR
Genesee & Wyoming Inc.
GWR
+$2.23M
5
MCRN
Milacron Holdings Corp.
MCRN
+$1.27M

Sector Composition

Rank Sector Weight
1 Communication Services 25.94%
2 Consumer Discretionary 12.54%
3 Healthcare 11.49%
4 Technology 9.42%
5 Financials 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLV icon
1
CALL
iShares Silver Trust
SLV
$27.1B
$16.7M 15%
+1,000,000
New +$16.2M
AGN
2
DELISTED
Allergan plc
AGN
$6.38M 5.74%
33,400
+12,000
+56% +$2.16M
AZO icon
3
AutoZone
AZO
$49.7B
$4.53M 4.07%
3,800
-200
-5% -$231K
EQIX icon
4
Equinix
EQIX
$101B
$4.31M 3.87%
7,383
– –
PARA
5
DELISTED
Paramount Global Class B
PARA
$4.25M 3.82%
101,263
+92,013
+995% +$3.56M
NXST icon
6
Nexstar Media Group
NXST
$5.61B
$3.61M 3.25%
30,813
– –
BOLD
7
DELISTED
Audentes Therapeutics, Inc
BOLD
$3.41M 3.07%
+57,000
New +$2.14M
NIHD
8
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$3.25M 2.93%
1,500,200
+500,200
+50% +$968K
GBL
9
DELISTED
GAMCO Investors, Inc.
GBL
$2.97M 2.67%
152,544
+80,000
+110% +$1.41M
AMCX icon
10
AMC Global Media
AMCX
$461M
$2.92M 2.63%
74,058
-7,240
-9% -$304K
DISCK
11
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$2.58M 2.32%
84,492
– –
ZAYO
12
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$2.43M 2.18%
70,000
+20,000
+40% +$685K
NXPI icon
13
NXP Semiconductors
NXPI
$67.3B
$2.37M 2.13%
18,622
-2,650
-12% -$308K
ROST icon
14
Ross Stores
ROST
$74.9B
$2.29M 2.06%
19,700
– –
WBC
15
DELISTED
WABCO HOLDINGS INC.
WBC
$2.03M 1.83%
+15,000
New +$2.02M
TGNA
16
DELISTED
TEGNA Inc
TGNA
$1.89M 1.7%
113,454
-20,100
-15% -$313K
CY
17
DELISTED
Cypress Semiconductor
CY
$1.87M 1.68%
80,100
– –
MSGS icon
18
Madison Square Garden
MSGS
$9.56B
$1.75M 1.57%
8,346
– –
MDCO
19
DELISTED
Medicines Co
MDCO
$1.7M 1.53%
+20,000
New +$1.33M
AC
20
DELISTED
Associated Capital Group
AC
$1.69M 1.52%
43,198
– –
MSGN
21
DELISTED
MSG Networks Inc.
MSGN
$1.63M 1.47%
93,803
-15,000
-14% -$250K
CZR
22
DELISTED
Caesars Entertainment Corporation
CZR
$1.63M 1.47%
120,000
– –
MSFT icon
23
Microsoft
MSFT
$2.93T
$1.55M 1.4%
9,843
– –
GPC icon
24
Genuine Parts
GPC
$17.2B
$1.46M 1.31%
13,700
– –
WBD icon
25
Warner Bros
WBD
$67.4B
$1.34M 1.21%
41,029
– –
1
2 3 4

Similar funds

FFMBT
First Farmers & Merchants Bank Trust Columbia, Tennessee $75.4M AUM 6.56% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
WM
Westpark Management Plano, Texas $75.3M AUM 22.07% 1-Year Est. Return
RA
Ratos AB Stockholm, Sweden $76.4M AUM
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
GI
Gavea Investimentos Rj, Brazil $77.6M AUM 64.56% 1-Year Est. Return
PM
Ponoi Management San Francisco, California $73.2M AUM 23.44% 1-Year Est. Return
PIMH
Prudence Investment Management (HK) 12 Harcourt Road Central, Hong Kong $78.2M AUM 52.44% 1-Year Est. Return

S. Muoio & Co's Q4 2019 Portfolio in Review

As of Q4 2019, S. Muoio & Co held 91 positions worth $111M, up 17% from $95.3M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

S. Muoio & Co deployed $9.02M of net new capital in Q4 2019, opening 16 new positions and adding to 10 existing holdings. Its largest new stake was Audentes Therapeutics, Inc: 57,000 shares worth $3.41M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, down from 29% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Phibro Animal Health, an estimated $1.02M trimmed.

  • S. Muoio & Co's largest Q4 2019 buy was Audentes Therapeutics, Inc: 57,000 shares worth $3.41M.
  • S. Muoio & Co added most to Paramount Global Class B in Q4 2019, an estimated $3.56M increase.
  • S. Muoio & Co's biggest Q4 2019 reduction was Phibro Animal Health, cutting an estimated $1.02M.
  • S. Muoio & Co fully exited Celgene Corp in Q4 2019, selling an estimated $7.92M.
  • S. Muoio & Co's ten largest holdings make up 47% of its $111M portfolio in Q4 2019.
  • S. Muoio & Co opened 16 new positions and closed 20 in Q4 2019.
  • S. Muoio & Co's portfolio value rose 17% quarter-over-quarter to $111M.

Based on S. Muoio & Co's 13F filing for Q4 2019, filed 12 Feb 2020.